These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2004406)
1. [The past and the present of cardiac glycosides. III. Pharmacokinetics]. Synek P Cas Lek Cesk; 1991 Feb; 130(5):148-51. PubMed ID: 2004406 [TBL] [Abstract][Full Text] [Related]
2. Current status of cardiac glycoside drug interactions. Hooymans PM; Merkus FW Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751 [TBL] [Abstract][Full Text] [Related]
3. Digitalis pharmacokinetics and therapy with respect to impaired renal function. Kramer P Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291 [TBL] [Abstract][Full Text] [Related]
6. Digitalis therapy in renal failure with special regard to digitoxin. Vöhringer HF; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432 [TBL] [Abstract][Full Text] [Related]
7. [Renal elimination kinetics of various several cardiac glycosides]. Kramer P; Scheler F Dtsch Med Wochenschr; 1972 Oct; 97(40):1485-90. PubMed ID: 5071762 [No Abstract] [Full Text] [Related]
8. [Modern cardiac glycoside therapy]. Bonelli J Wien Med Wochenschr; 1978; 128(22):689-96. PubMed ID: 735108 [No Abstract] [Full Text] [Related]
9. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. Caldwell JH; Greenberger NJ J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. Smith TW J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586 [TBL] [Abstract][Full Text] [Related]
11. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency]. Rietbrock N; Woodcock BG; Hrazdil U Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927 [TBL] [Abstract][Full Text] [Related]
12. On the ocular distribution of cardiac glycosides in guinea pigs following acute administration. Duncker G; Herzig S Graefes Arch Clin Exp Ophthalmol; 1989; 227(1):55-9. PubMed ID: 2920909 [TBL] [Abstract][Full Text] [Related]
13. [FACTORS INFLUENCING THE ACTION OF CARDIAC GLYCOSIDES ON ISOLATED EMBRYONIC CHICK HEART. I. EFFECTS OF SERUM AND CORTISOL ON THE ACTION OF CARDIAC GLYCOSIDES]. UCHIDA S Yakugaku Zasshi; 1964 Jul; 84():596-601. PubMed ID: 14221199 [No Abstract] [Full Text] [Related]
14. Elimination of cardiac glycosides through hemofiltration. Kramer P; Matthias C; Matthaei D; Scheler F J Dial; 1977; 1(7):689-95. PubMed ID: 608877 [TBL] [Abstract][Full Text] [Related]
15. Influence of induced cholestasis on pharmacokinetics of digoxin and digitoxin in dogs. Miyazawa Y; Sato T; Kobayashi K; Akahori F; Suzuki T; Miyashita H Am J Vet Res; 1990 Apr; 51(4):605-10. PubMed ID: 2327624 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy. Kuhlmann J Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430 [TBL] [Abstract][Full Text] [Related]
17. [Effective concentration and dosage for cardiac glycosides]. Weiss M; Förster W Z Gesamte Inn Med; 1980 Jan; 35(1):1-7. PubMed ID: 6996345 [TBL] [Abstract][Full Text] [Related]
18. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides. Reissell P; Manninen V Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097 [TBL] [Abstract][Full Text] [Related]
19. [Possibilities and problems or long-term therapy using cardiac glycosides]. Gillmann H Z Gesamte Inn Med; 1973 Feb; 28(3):41-5 passim. PubMed ID: 4633782 [No Abstract] [Full Text] [Related]
20. [Therapy of chronic cardiac insufficiency with cardiac glycosides]. Bonelli J Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995 [No Abstract] [Full Text] [Related] [Next] [New Search]